Skip to main content
editorial
. 2015 Aug 22;6(28):24584–24585. doi: 10.18632/oncotarget.5245

Figure 1. Signaling pathways downstream of ICOS and ICOS-L may differentially contribute to the cytokine production and survival of ILC2s.

Figure 1